GTHX Annual D&A
$513.00 K
-$17.00 K-3.21%
31 December 2023
Summary:
As of January 23, 2025, GTHX annual depreciation & amortization is $513.00 thousand, with the most recent change of -$17.00 thousand (-3.21%) on December 31, 2023. During the last 3 years, it has fallen by -$69.00 thousand (-11.86%).GTHX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Quarterly D&A
$121.00 K
+$1000.00+0.83%
30 June 2024
Summary:
As of January 23, 2025, GTHX quarterly depreciation & amortization is $121.00 thousand, with the most recent change of +$1000.00 (+0.83%) on June 30, 2024. Over the past year, it has dropped by -$9000.00 (-6.92%).GTHX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX TTM D&A
$492.00 K
-$9000.00-1.80%
30 June 2024
Summary:
As of January 23, 2025, GTHX TTM depreciation & amortization is $492.00 thousand, with the most recent change of -$9000.00 (-1.80%) on June 30, 2024. Over the past year, it has dropped by -$46.00 thousand (-8.55%).GTHX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GTHX Depreciation And Amortization Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -3.2% | -6.9% | -8.6% |
3 y3 years | -11.9% | -6.9% | -8.6% |
5 y5 years | +193.1% | +86.2% | -9.6% |
GTHX Depreciation And Amortization High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | ||||||
5 y | 5-year | ||||||
alltime | all time | -11.9% | -23.9% | -18.4% |
G1 Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | $121.00 K(+0.8%) | $492.00 K(-1.8%) |
Mar 2024 | - | $120.00 K(-3.2%) | $501.00 K(-2.3%) |
Dec 2023 | $513.00 K(-3.2%) | $124.00 K(-2.4%) | $513.00 K(-2.5%) |
Sept 2023 | - | $127.00 K(-2.3%) | $526.00 K(-2.2%) |
June 2023 | - | $130.00 K(-1.5%) | $538.00 K(-1.6%) |
Mar 2023 | - | $132.00 K(-3.6%) | $547.00 K(+3.2%) |
Dec 2022 | $530.00 K(+13.0%) | $137.00 K(-1.4%) | $530.00 K(+4.5%) |
Sept 2022 | - | $139.00 K(0.0%) | $507.00 K(+4.5%) |
June 2022 | - | $139.00 K(+20.9%) | $485.00 K(+4.5%) |
Mar 2022 | - | $115.00 K(+0.9%) | $464.00 K(-1.1%) |
Dec 2021 | $469.00 K(-19.4%) | $114.00 K(-2.6%) | $469.00 K(-1.3%) |
Sept 2021 | - | $117.00 K(-0.8%) | $475.00 K(-5.6%) |
June 2021 | - | $118.00 K(-1.7%) | $503.00 K(-7.4%) |
Mar 2021 | - | $120.00 K(0.0%) | $543.00 K(-6.7%) |
Dec 2020 | $582.00 K | $120.00 K(-17.2%) | $582.00 K(-3.5%) |
Sept 2020 | - | $145.00 K(-8.2%) | $603.00 K(+10.8%) |
June 2020 | - | $158.00 K(-0.6%) | $544.00 K(+20.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $159.00 K(+12.8%) | $451.00 K(+26.7%) |
Dec 2019 | $356.00 K(+103.4%) | $141.00 K(+64.0%) | $356.00 K(+29.5%) |
Sept 2019 | - | $86.00 K(+32.3%) | $275.00 K(+16.0%) |
June 2019 | - | $65.00 K(+1.6%) | $237.00 K(+14.5%) |
Mar 2019 | - | $64.00 K(+6.7%) | $207.00 K(+18.3%) |
Dec 2018 | $175.00 K(+96.6%) | $60.00 K(+25.0%) | $175.00 K(+20.7%) |
Sept 2018 | - | $48.00 K(+37.1%) | $145.00 K(+16.9%) |
June 2018 | - | $35.00 K(+9.4%) | $124.00 K(+13.8%) |
Mar 2018 | - | $32.00 K(+6.7%) | $109.00 K(+22.5%) |
Dec 2017 | $89.00 K(+32.8%) | $30.00 K(+11.1%) | $89.00 K(+8.5%) |
Sept 2017 | - | $27.00 K(+35.0%) | $82.00 K(+12.3%) |
June 2017 | - | $20.00 K(+66.7%) | $73.00 K(+9.6%) |
Mar 2017 | - | $12.00 K(-47.8%) | $66.60 K(-0.6%) |
Dec 2016 | $67.00 K(+59.5%) | $23.00 K(+27.8%) | $67.00 K(+52.3%) |
Sept 2016 | - | $18.00 K(+32.4%) | $44.00 K(+69.2%) |
June 2016 | - | $13.60 K(+9.7%) | $26.00 K(+109.7%) |
Mar 2016 | - | $12.40 K | $12.40 K |
Dec 2015 | $42.00 K | - | - |
FAQ
- What is G1 Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for G1 Therapeutics?
- What is G1 Therapeutics annual D&A year-on-year change?
- What is G1 Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for G1 Therapeutics?
- What is G1 Therapeutics quarterly D&A year-on-year change?
- What is G1 Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for G1 Therapeutics?
- What is G1 Therapeutics TTM D&A year-on-year change?
What is G1 Therapeutics annual depreciation & amortization?
The current annual D&A of GTHX is $513.00 K
What is the all time high annual D&A for G1 Therapeutics?
G1 Therapeutics all-time high annual depreciation & amortization is $582.00 K
What is G1 Therapeutics annual D&A year-on-year change?
Over the past year, GTHX annual depreciation & amortization has changed by -$17.00 K (-3.21%)
What is G1 Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GTHX is $121.00 K
What is the all time high quarterly D&A for G1 Therapeutics?
G1 Therapeutics all-time high quarterly depreciation & amortization is $159.00 K
What is G1 Therapeutics quarterly D&A year-on-year change?
Over the past year, GTHX quarterly depreciation & amortization has changed by -$9000.00 (-6.92%)
What is G1 Therapeutics TTM depreciation & amortization?
The current TTM D&A of GTHX is $492.00 K
What is the all time high TTM D&A for G1 Therapeutics?
G1 Therapeutics all-time high TTM depreciation & amortization is $603.00 K
What is G1 Therapeutics TTM D&A year-on-year change?
Over the past year, GTHX TTM depreciation & amortization has changed by -$46.00 K (-8.55%)